Target intelligence / Profile preview

Ubiquitin protein ligase E3 component n-recognin 4 (UBR4)

Target
UBR4
Molecular classification
Enzyme (E3 ubiquitin ligase, E4 ligase), Other (cytoskeletal-associated protein, chromatin scaffold component)
01

Overview

Ubiquitin protein ligase E3 component n-recognin 4 (UBR4) is a very large, multifunctional E3 and E4 ubiquitin ligase that plays a critical role in cellular protein quality control systems, including the N-end rule pathway and related degradation pathways[1][2][3][4][5]. UBR4 recognizes and ubiquitinates proteins with destabilizing N-terminal residues (N-degrons), facilitating their degradation primarily via the ubiquitin-proteasome system. It also works as an E4 ligase, amplifying ubiquitination signals by specifically extending lysine-48-linked ubiquitin chains on misfolded, aggregated, or otherwise unwanted proteins—frequently operating as part of multi-subunit complexes with cofactors such as KCMF1 and calmodulin[1][4]. UBR4 is involved in crucial stress-response pathways, including the clearance of oxidized proteins and regulation of stress-induced autophagy. It interacts with key cellular structures, functioning as both a cytoskeletal component in the cytoplasm and a chromatin scaffold in the nucleus[3][5]. UBR4 is essential for proteostasis in long-lived, metabolically active cells such as neurons and muscle cells; mutations or dysregulation of UBR4 have been linked to neurodegeneration, muscular atrophy, and cancer progression[2][3][4]. Its requirement in multiple protein quality control and cell surveillance mechanisms makes it a potential—but complicated—therapeutic target, as its inhibition could risk widespread proteostasis disruption. No drugs are currently known to directly modulate UBR4 in clinical use or trials[3][4].

Other names
UBR4KIAA0462KIAA1307p600RBAF600ZUBR1retinoblastoma-associated factor of 600 kDa600 kDa retinoblastoma protein-associated factorN-recognin-4E3 ubiquitin-protein ligase UBR4RING-type E3 ubiquitin transferase UBR4retinoblastoma-associated factor 600-like proteinzinc finger UBR1-type protein 1
02

Biological functions

Protein quality controlUbiquitin-proteasome-mediated degradationAutophagy pathway regulationStress response signalingMaintenance of cellular proteostasisChromatin scaffold function
03

Disease associations

CancerNeurodegenerative diseaseMyopathy/muscular atrophyRare developmental diseases (e.g., Alternating Hemiplegia of Childhood 2, Long QT syndrome)
04

Safety considerations

Therapeutic targeting challenges due to essential roles in proteostasis and cell viability[4][1][2]

Beyond the preview

Go deeper on Ubiquitin protein ligase E3 component n-recognin 4 (UBR4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin protein ligase E3 component n-recognin 4 (UBR4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call